Zobrazeno 1 - 8
of 8
pro vyhledávání: '"G V, Lilitsa"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 1, Pp 33-36 (2015)
Aim. To study clinical efficacy of a new domestic metabolic drug Eltacine in patients with chronic heart failure (CHF).Material and methods. 134 patients with CHF of I-III functional classes were randomized in two parallel groups of patients receivin
Externí odkaz:
https://doaj.org/article/25945540544a4a5f84452800fa370462
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 3, Iss 1, Pp 33-36 (2015)
Aim. To study clinical efficacy of a new domestic metabolic drug Eltacine in patients with chronic heart failure (CHF).Material and methods. 134 patients with CHF of I-III functional classes were randomized in two parallel groups of patients receivin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fdb777a899373fd7cd596026e2451c
https://www.rpcardio.com/jour/article/view/382
https://www.rpcardio.com/jour/article/view/382
Publikováno v:
Klinicheskaia meditsina. 88(3)
The aim of the work was to assess effectiveness of melatonin monotherapy (MT) and combined treatment (CT) in aged patients with arterial hypertension (AH) and coronary heart disease (CHD). A group of 170 patients (mean age 64 years) included 61 ones
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a76d808d98c318e3a8b4948e1622b1aa
https://pubmed.ncbi.nlm.nih.gov/20608060
https://pubmed.ncbi.nlm.nih.gov/20608060
Publikováno v:
Klinicheskaia meditsina. 82(12)
Forty-four patients with coronary heart disease, angina pectoris, prior myocardial infarction, and NYHA Functional Class II-IV heart failure were examined. Group 1 patients received emoxypine during combined therapy (CT). Group 2 patients took CT alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7b67f3ffab615ad0235c9ee84fdecbe
https://pubmed.ncbi.nlm.nih.gov/15732713
https://pubmed.ncbi.nlm.nih.gov/15732713
Autor:
R M, Zaslavskaia, G V, Lilitsa
Publikováno v:
Klinicheskaia meditsina. 82(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f78b2459e67e9d4e86c10b28fed48bac
https://pubmed.ncbi.nlm.nih.gov/15344682
https://pubmed.ncbi.nlm.nih.gov/15344682
Publikováno v:
Klinicheskaia meditsina. 82(4)
We studied pharmacodynamics of an amino acids complex (AAC) in 60 elderly patients (a mean age 71.6 years) with ischemic heart disease, postinfarction cardiosclerosis (PIC), circulatory insufficiency stage I-II. The patients were randomized into 3 gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17fb86dafd8582499ddde10702f86232
https://pubmed.ncbi.nlm.nih.gov/15164511
https://pubmed.ncbi.nlm.nih.gov/15164511
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 59(6)
The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc8337f3997f442f6f8c5ef9c10a2d54
https://pubmed.ncbi.nlm.nih.gov/9181866
https://pubmed.ncbi.nlm.nih.gov/9181866
Publikováno v:
Klinicheskaia meditsina. 74(9)
Time-related effect of betapressin (penbutolol) has been studied in 24 patients with essential hypertension stage II. The drug was given in the morning, afternoon and evening in a dose 40 mg. Control group consisted of 20 patients with essential hype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87fe8e73514091d305ef8e3c1fe45b3a
https://pubmed.ncbi.nlm.nih.gov/9121089
https://pubmed.ncbi.nlm.nih.gov/9121089